|
|
 |
|
Viewing report
|
|
|
|
Financial Innovation in the Pharmaceutical Industry
Informa Healthcare, May 2009, Pages: 12
How will the biopharmaceutical industry get through the capital crisis? In the face of unprecedented industry challenges, companies are paring their businesses down to the essentials, showing increased flexibility and novelty in deal-making, and concentrating on the medium term. This Scrip analysis weighs up the innovative survival strategies available to them.
Key topics covered:
- Impact of the credit crunch on the innovator biotech industry; financing activity; venture deals; initial public offerings (IPOs)
- Investors experimenting with new financing models
- Impact of the credit crunch on big pharma
- New financing model case studies: VIPEs (venture investment in public equity); royalty-based financing; committed equity finance facilities (CEFFs); venture debt; warrants; finance from corporates; contingent value rights; deal renegotiations
- Governments wading into the financing game
- New biotech financing models for investment banks
- Reverse mergers
- What future for IPOs?
- A look at London's AIM
- New ideas in venture capital
Customers who bought this item also bought
Fueling the Drug Discovery Engine: Biotech Investment and Business Trends
A Global Recession Drives New Business Strategies and Evolving Business Models in the Biopharma Industry
Successful Pharmabiotech Alliance Strategies: Driving Synergies, Avoiding Failure and Managing Relationships
How Big Pharma's R&D Focus Is Changing
The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology
Special Report: Successes and Lessons Learned in the Pharmaceutical Industry, 2009
Special Report: State of the Pharmaceutical Industry, 2009
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
State of the Pharmaceutical Industry, 2010 - Critical Role of Midsize Pharma
Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
|
|
|
|
